4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049447
EVP & Chief R & QA Officer sold 3,021 shares at $14.33 ($43,291)
- EVP & Chief R & QA Officer acquired 7,211 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…